NC-605

N/A

Report date: 2024/01/26 15:36:00

Base Information

Drug NameNC-605
Drug Alias NameNC-605NC605
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody
Mechanisms of ActionSialic acid-binding Ig-like lectin 15 binders
TargetsSialic acid-binding Ig-like lectin 15
Therapy Area/IndicationsOsteogenesis Imperfecta
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNextcure Inc
China Registration ClassN/A

Develop Information

Active CompaniesNextcure Inc
Inactive CompaniesN/A
Active IndicationsOsteogenesis Imperfecta
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A